RENAL PELVIS CANCER
Clinical trials for RENAL PELVIS CANCER explained in plain language.
Never miss a new study
Get alerted when new RENAL PELVIS CANCER trials appear
Sign up with your email to follow new studies for RENAL PELVIS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called LY4101174 in people with advanced or metastatic solid tumors, including bladder, breast, lung, and other cancers. The goal is to find a safe and effective dose and see if the drug can shrink tumors. About 490 participants will take p…
Matched conditions: RENAL PELVIS CANCER
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 05, 2026 11:52 UTC
-
Massive cancer registry aims to unlock genetic secrets of urinary cancers
Knowledge-focused OngoingThis study creates a large registry of over 3,500 people, including those with and without urothelial cancer (bladder, ureter, or kidney pelvis cancer). Researchers collect saliva samples and health information to find genetic markers and risk factors linked to the disease. The g…
Matched conditions: RENAL PELVIS CANCER
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 04:44 UTC